2025
Correlates of Impaired Sleep Duration Among Adults With Trauma Alone and With Posttraumatic Stress Disorder
Havlik J, Rhee T, Rosenheck R. Correlates of Impaired Sleep Duration Among Adults With Trauma Alone and With Posttraumatic Stress Disorder. Psychological Trauma Theory Research Practice And Policy 2025 PMID: 39836166, DOI: 10.1037/tra0001846.Peer-Reviewed Original ResearchImpaired sleep durationStress disorderSleep durationEffect sizePosttraumatic stress disorderClinically meaningful effect sizesNational Epidemiologic SurveyMeaningful effect sizesPsychiatric multimorbidityPTSDTrauma/PTSDImprove treatment outcomesMedical comorbiditySleep disturbanceImpaired sleepBehavioral variablesTreatment outcomesAllostatic loadNationally Representative SampleAdjusted multivariable regressionEpidemiological surveyDisordersBody mass indexRepresentative sampleSleep
2024
Typologies of Psychiatric Diagnoses Among Inpatients with Recent Suicide Attempts
Lord K, Tolin D, Diefenbach G. Typologies of Psychiatric Diagnoses Among Inpatients with Recent Suicide Attempts. Archives Of Suicide Research 2024, ahead-of-print: 1-16. PMID: 39302084, DOI: 10.1080/13811118.2024.2405732.Peer-Reviewed Original ResearchLatent class analysisSuicide attemptsComorbidity classesBattery of self-report measuresComorbidity of psychiatric disordersSemi-structured diagnostic interviewHistory of suicide attemptsPerson-centered statistical approachPatterns of comorbiditySelf-report measuresSuicide risk assessmentSuicide risk factorsDiagnostic heterogeneityDiagnostic InterviewCognitive-AffectivePsychiatric disordersSuicidal ideationPsychiatric diagnosingPsychiatric multimorbidityAttempted SuicideInterrupted attemptsActual attemptsSuicideComorbidityClass analysis
2021
A population‐wide perspective on the reach of substance use disorders: Parental exposure, diagnostic remission, and current disorders
Na PJ, Stefanovics EA, Rhee TG, Rosenheck RA. A population‐wide perspective on the reach of substance use disorders: Parental exposure, diagnostic remission, and current disorders. American Journal On Addictions 2021, 31: 69-79. PMID: 34921471, DOI: 10.1111/ajad.13246.Peer-Reviewed Original ResearchConceptsCurrent substance use disorderSubstance use disordersParental substance use disordersCurrent disorderUse disordersDiagnostic remissionUS populationChildhood adversityMultivariable-adjusted logistic regressionMental health-related qualityPoorer mental health-related qualityLifetime substance use disorderHealth-related qualityPopulation-based estimatesRelated Conditions Wave IIIUS adult populationNational Epidemiologic SurveyPublic health impactPsychiatric comorbidityFunctional impairmentPsychiatric disordersEpidemiologic SurveyWave IIIUnaffected groupPsychiatric multimorbidity
2019
Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders
Rhee TG, Rosenheck RA. Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders. Journal Of Affective Disorders 2019, 252: 450-457. PMID: 31004825, PMCID: PMC6520147, DOI: 10.1016/j.jad.2019.04.018.Peer-Reviewed Original ResearchConceptsPsychotropic polypharmacyDepressive disorderDepressed adultsPsychiatric careNational Ambulatory Medical Care SurveyPsychiatric multimorbidityAmbulatory Medical Care SurveyPrevalence of polypharmacyAdjunctive treatment strategyMore psychotropic medicationsOutpatient psychiatric careContext of multimorbidityPrescription combinationsPsychiatric polypharmacyPsychotropic classesPsychotropic medicationsCare SurveyPolypharmacyTreatment strategiesMultimorbidityAdultsCareAntipsychoticsAntidepressantsDisorders
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply